Valuation: Boston Scientific Corporation

Market Cap 62.37B 56.62B 52.3B 47.19B 89.08B 5,827B 92.49B 630B 249B 3,145B 234B 229B 9,935B P/E 2026 *
17.6x
P/E 2027 * 18.7x
Enterprise Value 72.86B 66.14B 61.1B 55.12B 104B 6,807B 108B 736B 291B 3,673B 273B 268B 11,605B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.34x
Free-Float
82.44%
Yield 2026 *
-
Yield 2027 * -
12/11 Boston Scientific Corporation Presents at Stifel 2026 Healthcare Conference 2026, Nov-11-2026 08:00 AM
07/11 Boston Scientific Neuromodulation Corporation Announces Nalu Td2 Therapy Disc Recall CI
03/11 Blackstone Life Sciences, Boston Scientific to Co-Fund Heart Pump MT
03/11 Blackstone, Boston Scientific Sign $455 Million Deal to Co-Fund Heart Pump DJ
03/11 Blackstone Life Sciences Announces Collaboration with Boston Scientific Corporation to Co-Fund Development of VITALYST Heart Pump CI
03/11 Boston Scientific Corporation Announces Positive Six-Month Primary Endpoint Results From SIMPLAAFY Randomized Controlled Trial of WATCHMAN FLX Pro Left Atrial Appendage Closure Device CI
31/10 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/TRANSEND/021/STRAIGHT/1RO/130; Material Number: M001195810 CI
31/10 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/027/STRAIGHT/1RO/130; Material Number: M001195410 CI
31/10 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/027/STRAIGHT/1RO/105; Material Number: M001195400 CI
31/10 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/027/BERN/1RO/105; Material Number: M001195430 CI
31/10 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/021/SWAN/1RO/155; Material Number: M001195310 CI
31/10 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/021/SWAN/1RO/105; Material Number: M001195290 CI
31/10 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/021/STRAIGHT/1RO/130; Material Number: M001195210 CI
1 day+1.17%
1 week-4.61%
Current month+2.55%
1 month-4.44%
3 months-14.70%
6 months-23.02%
Current year-54.85%
1 week 42.5
Extreme 42.5
45.6
1 month 39.57
Extreme 39.57
46.97
Current year 39.57
Extreme 39.57
100.9
1 year 39.57
Extreme 39.57
101.91
3 years 39.57
Extreme 39.57
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap. Importance
4/11/26 Don

Chief Executive Officer

252,241 0.0171%
1/11/26 Exercice

Head of Human Resources

9,614 0.0007%
25/8/26 Buy

Director

2,040 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+1.51%-4.61%-56.61%-20.95% 62.37B
-0.13%-4.02%+19.59%+46.87% 254B
+0.42%-3.74%+0.44%+7.34% 159B
-1.00%-5.37%-22.20%+36.63% 149B
-0.06%-0.51%+25.27%+56.68% 60.62B
+0.80%0.00%+4.69%-12.96% 53.05B
+1.02%-1.45%+21.24%+53.00% 48.55B
-1.61%-6.45%+4.17%+59.55% 46.7B
+2.03%-2.20%+22.28%+76.50% 44.21B
+0.55%-0.29%+15.97%+12.31% 37B
Average +0.35%-2.25%+3.48%+31.50% 92B
Weighted average by Cap. +0.11%-2.93%+3.05%+31.90%

Financials

2026 *2027 *
Net sales 20.97B 19.04B 17.58B 15.86B 29.95B 1,959B 31.09B 212B 83.81B 1,057B 78.67B 77.02B 3,340B 20.88B 18.95B 17.51B 15.79B 29.82B 1,951B 30.96B 211B 83.44B 1,053B 78.33B 76.68B 3,326B
Net income 3.53B 3.21B 2.96B 2.67B 5.04B 330B 5.24B 35.69B 14.12B 178B 13.25B 12.97B 563B 3.27B 2.97B 2.74B 2.47B 4.67B 306B 4.85B 33.06B 13.08B 165B 12.27B 12.02B 521B
Net Debt 10.48B 9.52B 8.79B 7.93B 14.97B 980B 15.55B 106B 41.9B 529B 39.34B 38.51B 1,670B 7.39B 6.71B 6.2B 5.59B 10.55B 690B 10.96B 74.66B 29.53B 372B 27.72B 27.14B 1,177B
Projected Income Statement - Annual - Boston Scientific Corporation
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
19/11/26 USD 43.04 +0.01% 3,310,044
17/11/26 USD 43.03 -1.51% 12,914,597
16/11/26 USD 43.69 -1.47% 16,109,271
13/11/26 USD 44.34 +0.32% 9,700,017
12/11/26 USD 44.20 -2.06% 11,505,058
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Boston Scientific Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
43.03USD
Average target price
49.60USD
Spread / Average Target
+15.27%